| Generic name | Deferasirox |
| Pronunciation | de-FER-a-sir-oks |
| Brand name(s), other common name(s) | Exjade® |
| Drug type | Iron chelator |
| How the drug is given | As a tablet for suspension (a tablet to dissolve in liquid) to take by mouth |
Indications and Usage
Deferasirox is FDA approved to remove excess iron that is in the body because of blood transfusions. Deferasirox works by attaching to iron molecules in the body so they can be excreted (removed from the body) in feces.
Side effects needing medical attention
Hearing loss; vision problems; decrease in urination; fever; unusual bleeding or bruising; lack of energy; loss of appetite; pain in the upper right part of the stomach; yellowing of the skin or eyes; hives; rash; difficulty breathing or swallowing; swelling of the face, throat, tongue, lips, eyes, hands, feet or ankles.
| Generic name | Deferasirox |
| Pronunciation | de-FER-a-sir-oks |
| Brand name(s), other common name(s) | Jadenu® |
| Drug type | Iron chelator |
| How the drug is given |
Tablet, for oral use |
Indications and Usage
Deferasirox is indicated for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older. This indication is approved under accelerated approval based on a reduction of liver iron concentrations and serum ferritin levels. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Side effects needing medical attention
Diarrhea, vomiting, nausea, abdominal pain, skin rashes, and increases in serum creatinine
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.